ALENDROVENIR

Country: Իսրայել

language: անգլերեն

source: Ministry of Health

active_ingredient:

ALENDRONIC ACID AS SODIUM 70 MG

MAH:

BIOAVENIR LTD

ATC_code:

M05BA04

pharmaceutical_form:

TABLETS

administration_route:

PER OS

manufactured_by:

WEST PHARMA- PROD. DE ESPEC. FARMACEUT.S.A.

therapeutic_group:

ALENDRONIC ACID

therapeutic_indication:

Alendronate Bioavenir is indicated for the treatment of osteoporosis in postmenopausal women to prevent fractures, including those of the hip and spine (vertebral compression fractures) .

authorization_date:

2010-03-01